CAS: 3820-67-5; 2,3-Dihydroxypropyl 2-(((7-Chloroquinolin-4-yl)Amino)Benzoate

该化合物是属于非类类类非类抗炎药物(NSAIDs)的化学化合物,主要以其止痛和抗炎特性著称,有助于治疗疼痛和炎症;该产品展示了类似于其他非类非亚类药物的一种行动机制,主要通过抑制环氧基酶(COX)酶,在合成疼痛和煽动反应中的异丙菊酯方面发挥着关键作用;Glafeyn的特征是其毒性特征相对于其他一些非亚种药物而言较低,尽管它仍然可能带来胃肠刺激和其他副作用的风险;其溶液和各种溶剂的稳定性可以影响其配制和药物应用的交付;与任何药物一样,Glaffin的利用应以医疗建议为指导,考虑到与其他药物和个人病人因素的潜在互动.

结构式图片

上下游产品

CAS号86-98-6 4,7-二氯喹啉 | CAS号71574-35-1 α-Glyceryl Anth... | CAS号118-48-9 靛红酸酐 | CAS号612-61-3 7-氯喹啉 | CAS号71574-35-1 α-Glyceryl Anth...

合成工艺路线路线简述

    📜靛红酸酐置于盐酸,Sodium Hydroxide体系中,用 甘油 用作溶剂,化学反应 1.67H,反应生成格拉非宁
    参考文献:A New,Convenient Synthesis Of Glafenine And Floctafenine
    标题:A New,Convenient Synthesis Of Glafenine And Floctafenine
    摘要:
    Doi:10.1055/s-1980-28923

    海关参考信息

    专利信息


    专利号:US-9051302-B2
    优先权日:2008-01-15
    标 题 :Synthesis of resorcylic acid lactones useful as therapeutic agents
    发明人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN
    权利人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN; UNIV STRASBOURG
    摘要:Disclosed are macrocyclic compounds of formulae I, I′, II, II′, III, III′, IV, and V, which are analogs of the pochonin resorcylic acid lactones, pharmaceutical compositions comprising the compounds, and methods and uses comprising the compounds for the treatment of diseases mediated by kinases and Heat Shock Protein 90 HSP90.

    专利号:US-2024287041-A1
    优先权日:2021-05-20
    标题 :Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
    发明人:BALOGLU ERKAN; AUSTAD BRIAN C; ROE DAVID G; KEDUC ANDREW; GOTTSCHLING STEPHEN EDMUND; HECKER EVAN
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The present invention relates to a method of preparing a compound represented by structural formula (VII), comprising reacting a compound represented by structural formula (II), with a compound represented by structural formula (III), in a solvent, in the presence of a Pd catalyst and one or more inorganic bases under conditions suitable to prepare a compound represented by structural formula (VII): The values and example values of the variables in structural formulas (VII), (II), and (III) are defined herein. The present invention also relates to crystalline Forms I and II of the compound represented by Structural Formula (VII), the use of the crystalline Forms in treating disease or disorders associated with CRM1 and method of preparing the crystalline Forms.

    专利号:US-4412075-A
    优先权日:1981-01-16
    标题 :Process for the preparation of quinolin-4-ones
    发明人:BAUDOUIN MICHEL; DESBOIS MICHEL
    权利人:RHONE POULENC SANTE
    摘要:1,2,3,4-Tetrahydroquinolin-4-ones of the formula: ##STR1## wherein R represents a hydrogen or halogen atom, an alkyl radical (1 to 4 carbon atoms), an alkoxy radical (1 to 4 carbon atoms) or the trifluoromethyl radical, and R 1 represents a hydrogen atom, an alkyl radical (1 to 4 carbon atoms) or the trifluoromethyl radical, are prepared by cyclizing a 3-anilinopropionic acid of the formula: ##STR2## (wherein R and R 1 are as hereinbefore defined) in a mixture of hydrofluoric acid and boron trifluoride. n The quinolinone products are useful intermediates in the synthesis of therapeutically active substances.

    专利号:AU-2022276509-A1
    优先权日:2021-05-20
    标题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

    专利号:US-9994558-B2
    优先权日:2013-09-20
    标题 :Multicyclic compounds and methods of using same
    发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM; MCCAULEY DILARA; LANDESMAN YOSEF; GOLAN GALI; KALID ORI; SHECHTER SHARON
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to compounds represented by Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders (e.g., PAK-mediated, for example, PAK4-mediated, diseases and disorders).

    专利号:WO-2022246227-A1
    优先权日:2021-05-20
    标 题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Alka K, Casey JR. Molecular phenotype of SLC4A11 missense mutants: Setting the stage for personalized medicine in corneal dystrophies. Hum Mutat. 2018 May;39(5):676-690. doi: 10.1002/humu.23401. Epub 2018 Feb 2. doi: 10.1124/jpet.117.241406. Epub 2017 Jun 19. doi: 10.1007/978-1-4939-3603-8_25. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.045. Epub 2016 May 5.
    5: Chiu AM, Mandziuk JJ, Loganathan SK, Alka K, Casey JR. High Throughput Assay Identifies Glafenine as a Corrector for the Folding Defect in Corneal Dystrophy-Causing Mutants of SLC4A11. Invest Ophthalmol Vis Sci. 2015 Dec;56(13):7739-53. doi: 10.1167/iovs.15-17802. doi: 10.1016/j.bcp.2014.11.006. Epub 2014 Nov 22. doi: 10.1242/dmm.009852. Epub 2012 Aug 23.
    8: Wen B, Moore DJ. Bioactivation of glafenine by human liver microsomes and peroxidases: identification of electrophilic iminoquinone species and GSH conjugates. Drug Metab Dispos. 2011 Sep;39(9):1511-21. doi: 10.1124/dmd.111.039396. Epub 2011 May 31. doi: 10.1167/iovs.10-5897.

    合成参考文献


    摘要:Farmaco, Edizione Scientifica., 38(847), 1983 []
    摘要:Therapie., 37(327), 1982 []
    摘要:Gekkan Yakuji. Pharmaceuticals Monthly., 22(1343), 1980
    摘要:U.S. Patent 3,232,944.
    参考文献:10.2165/00002018-199615010-00005
    摘要:Manoukian AV, Carson JL. Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention. Drug Saf. 1996 Jul;15(1):64–71. doi: 10.2165/00002018-199615010-00005.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知